You just read:

Emmaus Life Sciences, Inc. Receives Notice of Allowance for U.S. Patent for use of L-glutamine in Treatment of Diverticulosis

News provided by

Emmaus Life Sciences, Inc.

01 Feb, 2017, 08:00 ET